Abstract:Nitric oxide (NO) is a key signalling molecule in the regulation of cardiometabolic function and impaired bioactivity is considered to play an important role in the onset and progression of cardiovascular and metabolic disease. Research has revealed an alternative NO-generating pathway, independent of NO synthase (NOS), in which the inorganic anions nitrate (NO3-) and nitrite (NO2-) are serially reduced to form NO. This work specifically aimed at investigating the role of commensal bacteria in bioactivation of dietary nitrate and its protective effects in a model of cardiovascular and metabolic disease. In a two-hit model, germ-free and conventional male mice were fed a western diet and the NOS inhibitor l-NAME in combination with sodium nitrate (NaNO3) or placebo (NaCl) in the drinking water. Cardiometabolic parameters including blood pressure, glucose tolerance and body composition were measured after six weeks treatment. Mice in both placebo groups showed increased body weight and fat mass, reduced lean mass, impaired glucose tolerance and elevated blood pressure. In conventional mice, nitrate treatment partly prevented the cardiometabolic disturbances induced by a western diet and l-NAME. In contrast, in germ-free mice nitrate had no such beneficial effects. In separate cardiovascular experiments, using conventional and germ-free animals, we assessed NO-like signalling downstream of nitrate by administration of sodium nitrite (NaNO2) via gavage. In this acute experimental setting, nitrite lowered blood pressure to a similar degree in both groups. Likewise, isolated vessels from germ-free mice robustly dilated in response to the NO donor sodium nitroprusside. In conclusion, our findings demonstrate the obligatory role of host-microbiota in bioactivation of dietary nitrate, thus contributing to its favourable cardiometabolic effects.

Therapeutic effects of inorganic nitrate and nitrite in cardiovascular and metabolic diseases

Dietary nitrate biochemistry and physiology. An update on clinical benefits and mechanisms of action

Dysfunctional and Dysregulated Nitric Oxide Synthases in Cardiovascular Disease: Mechanisms and Therapeutic Potential

Characterization of the Role of Nitric Oxide and Its Clinical Applications

Dietary inorganic nitrate reverses features of metabolic syndrome in endothelial nitric oxide synthase-deficient mice

Does dietary nitrate say NO to cardiovascular ageing? Current evidence and implications for research

The Cardioprotective Role of Nitrate-Rich Vegetables

Nitric oxide-mediated metabolic regulation during exercise: effects of training in health and cardiovascular disease

The obligatory role of host microbiota in bioactivation of dietary nitrate

Nitrite reduces angiotensin II-mediated contractions of the renal microcirculation by reducing NADPH oxidase activity and increasing nitric oxide bioavailability

Nitric Oxide Regulation of Myocardial O2 Consumption and HEP Metabolism.

Nitrate and Nitrite in Health and Disease

Nitric oxide synthase uncoupling: a therapeutic target in cardiovascular diseases.

Progress in inhibitors of nitric oxide synthase

The Effect of Nitric Oxide on Cardiovascular Disease

Nitric oxide in the cardio-cerebrovascular system: Source, regulation and application

Exogenous NO Therapy for the Treatment and Prevention of Atherosclerosis

Facilitating Nitrite-Derived S-Nitrosothiol Formation in the Upper Gastrointestinal Tract in the Therapy of Cardiovascular Diseases

Nitric oxide-dependent endothelial function and cardiovascular disease

Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation

Nitric oxide and energy metabolism in mammals.